Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
11,891.55-45.95
Stock Analysis, IPO, Mutual Funds, Bonds & More

IDFC Securities maintains outperformer on Sanofi India, target price Rs 7,368

Outperform Sanofi India Ltd. at a price target of Rs 7368.0 .

Updated: Nov 14, 2019, 08.39 AM IST
0Comments
ThinkStock Photos
Buy-sale12
IDFC Securities has maintained outperformer rating on Sanofi India in the long term with a target price of Rs 7368. The stock ended down 0.1% at Rs 6599.95 on Wednesday while the BSE Sensex closed 229.02 points down at 40,116.06.

Company Financials

For the quarter ended 30-09-2019, the company has reported standalone sales of Rs 779.10 crore, up 4.17% from last quarter sales of Rs 747.90 crore and up 11.20% from last year same quarter sales of Rs 700.60 crore. The company has reported net profit after tax of Rs 126.60 crore in the latest quarter.

Investment Rationale

The brokerage has maintained rating on the stock given attractive valuations and steady improvement in operating performance. The stock trades at 20.7 times EV/ EBITDA and 31.2 times CY20 estimated price-to-earnings ratio, which are at discount to those of MNC peers like Glaxo, said IDFC Securities.

Also Read

Dharmesh Mehta to acquire IDFC Securities

IDFC Securities neutral on Dish TV India, target price Rs 19

IDFC Securities has underperformer on Bank of India, target price Rs 60

IDFC Securities rates SRF outperformer, target price Rs 3,347

Coffee Day Enterprises ropes in IDFC Securities to identify strategic options

Comments
Add Your Comments
Commenting feature is disabled in your country/region.
Download The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
Disclaimer: This recommendation is analyst's own and does not represent those of economictimes.com & ETMarkets.com. Please consult your financial advisor before taking any position in the stock/s mentioned.

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service